www.fdanews.com/articles/189187-diabeloop-receives-ce-mark-for-blood-sugar-monitoring-technology
Diabeloop Receives CE Mark for Blood Sugar Monitoring Technology
November 14, 2018
Diabeloop’s DBLG1 technology for monitoring and maintaining blood sugar levels has earned the CE Mark.
The self-learning, customizable system can mimic the pancreas’ insulin-dispensing functions and adapt to the patient.
The DBLG1 links to a continuous blood glucose monitoring system and an insulin patch pump to predict glucose levels and optimally control the pump.